For the first time, Colin Farrell has opened up his home and talked in-depth about life with his son James, who has Angelman syndrome. James was just a toddler when he was diagnosed with the rare ...

Colin Farrell says his personal life has inspired him to launch a new foundation aimed at helping people with intellectual disabilities. The actor, 48, recently launched the Colin Farrell Foundation, ...

Irish actor Colin Farrell has shared an emotional account of why he and his former partner, Kim Bordenave, decided to place their 21-year-old son, James, who was initially misdiagnosed with cerebral ...

This post was updated on April 24, 2019 to incorporate feedback from parents. Names have been changed to protect anonymity. Is this child happy? Source: Joel Frohlich (AI generated with Midjourney) ...

Colin Farrell is honoring his son by starting a new foundation to help people with intellectual disabilities. The Oscar-nominated actor, 48, has launched the Colin Farrell Foundation, which is ...

Affected populations: The disorder is believed to affect somewhere between 1 in 12,000 and 1 in 24,000 people, although these figures may be underestimated. Many cases of Angelman syndrome can go ...

Colin Farrell is opening up about life with his 20-year-old son who has Angelman syndrome. The Irish actor is sharing details of James’ life as they prepare for his 21st birthday, a milestone when ...

Colin Farrell is starting a foundation to honor his son James — and giving a rare glimpse at their life together in the process. The actor gushed about his “magic” 21-year-old, who has Angelman ...

SARASOTA, Fla. and NOVATO, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the ...

NISSWA — Two bicyclists are embarking on a 4,200-mile trip across the country for a deeply personal cause. Known as “Bike 4 Briar,” the team includes Todd Downey and Charlie Nuck, who seek to raise ...

CARLSBAD, Calif., September 09, 2025--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy ...